Glioblastoma Multiforme Brain Tumor – HOPE is Here!

by Glioblastoma Prognosis on September 15, 2010

The prognosis for a Glioblastoma multiforme brain tumor is not good but I am writing to offer you hope. Wikipedia quotes Glioblastoma multiforme brain tumor as “the most common and most aggressive type of primary brain tumor in humans, involving glial cells and accounting for 52% of all parenchymal brain tumor cases and 20% of all intracranial tumors…. treatments involve chemotherapy, radiation, radiosurgery, corticosteroids, antiangiogenic therapy, and surgery… Glioblastoma has a very poor prognosis, despite multimodality treatment consisting of open craniotomy with surgical resection of as much of the tumor as possible, followed by concurrent or sequential chemoradiotherapy, antiangiogenic therapy with bevacizumab, gamma knife radiosurgery, and symptomatic care with corticosteroids.”   The patient’s doctor and oncology team has probably relayed the same information.

Treatment of a Glioblastoma Multiforme Brain Tumor is very difficult due to several complicating factors including:

  • tumor cells are very resistant to other conventional therapies
  • patient is susceptible to brain damage with conventional therapy (surgery is extremely invasive)
  • the brain has a very limited capacity to repair itself (neurological cells are designed to live a long time and not designed to regenerate as many other cells in our body were – so the brain does not readily “heal itself”)
  • many drugs cannot cross the blood-brain barrier to act on the tumor

HOPE for those with Glioblastoma Multiforme Brain Tumor and other cancers!!

Medical scientists and researchers have known since 2007 that the damage to the mitochondria in Glioblastoma Multiforme Brain Tumors and other cancerous growths can be reactivated. Once the mitochondria is reactivated,  the Glioblastoma Multiforme Brain Tumor (transplanted into rats and treated for 3 weeks) shrank by 70%.  The results were better than the research team, lead by Dr. Michelakis, were hoping for. This landmark medical discovery was discovered at the University of Alberta (UA) in Canada.  In January of 2007, a reputable periodical “Cancer Cell” published the results of the study conducted by the Canadian researchers.

You would think that the cure or treatment of Glioblastoma Multiforme Brain Tumor and other cancers would be widely received. Although happily received by the populace (see videos by Global News, CTV News, and the Real Story on sodium dichloroacetate visit, it was not received well by the pharmeuceutical companies and governments because there is no money in it!!!

The reasearchers proved that deadly Glioblastoma Multiforme Brain Tumor and other cancers can be treated – orally (by the mouth) by a simple molecule called DCA. DCA is also known as NaDCA, Dichloroacetate, and Sodium Dichloroacetate. The private pharmaceutical concerns are not interested in conducting clinical trials because DCA is a simple molecule and, therefore, cannot be patented. If it cannot bring profit to a given company they will not fund more research.

It is important to note, DCA has already been tested on both healthy and sick patients.

DCA, Sodium Dichloroacetate was found to be:

  • non-toxic
  • odorless
  • a simple molecule
  • a small molecule, allowing easy  absorbion
  • a small enough molecular size to allows it to cross the blood-brain barrier
  • successfully used in treatment of inborn defects connected with metabolism
  • used for more than 20 years on patients with lactic acidosis to reactivate their cellular mitochondria
  • inexpensive
  • readily available

If you or a loved one has a Glioblastoma Multiforme Brain Tumor, you can buy DCA , it is available without a prescription.

Previous post:

Next post: